4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001325812-15-000051
$ALNYCIK 0001178670operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:36 PM ET
Size
5.3 KB
Accession
0001325812-15-000051
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2015-06-08+140,000→ 140,000 totalExercise: $129.97Exp: 2025-06-08→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:36 PM ET
- Size
- 5.3 KB